Cambrex is a global CDMO that provides drug substance, drug product, and analytical services across the entire drug development life cycle. Based in New Jersey, Cambrex has over 40 years of experience and operates in North America and Europe. The company’s drug substance capabilities include biocatalysis, continuous flow, controlled substances, solid-state science, material characterization, and HPAPIs. With IND-enabling services and GMP manufacturing of custom and generic APIs, Cambrex offers discovery through commercial services.
